Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
Journal
Frontiers in Oncology
Journal Volume
13
Date Issued
2023
Author(s)
Lee, Po-Hsin
Tseng, Jeng-Sen
Zheng, Zhe-Rong
Chen, Kun-Chieh
Chu, Cheng-Hsiang
Huang, Yen-Hsiang
Hsu, Kuo-Hsuan
Yang, Tsung-Ying
Liu, Tsang-Wu
Hsia, Jiun-Yi
Chang, Gee-Chen
Abstract
For patients with T2aN0 stage IB lung adenocarcinoma, benefits of adjuvant chemotherapy remain controversial. Here, we aimed to evaluate such benefits.
Subjects
T2aN0; adjuvant chemotherapy; early lung cancer; lung adenocarcinoma; stage IB
Publisher
FRONTIERS MEDIA SA
Type
journal article